Patents by Inventor Timothy E. Kennedy

Timothy E. Kennedy has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 12252710
    Abstract: The present disclosure concerns a cell or tissue culture system comprising a solid support for the culture of adherent cells or adherent tissues and a plurality of cationic dendrimers associated to the surface of the solid support. Each cationic dendrimer includes one or more functional amine group. The cationic dendrimer is protonated at physiological pH. The cell or tissue culture system can be used for the culture of adherent cells or tissues and be used for the differentiation of stem cells.
    Type: Grant
    Filed: April 19, 2022
    Date of Patent: March 18, 2025
    Assignee: THE ROYAL INSTITUTION FOR THE ADVANCEMENT OF LEARNING/MCGILL UNIVERSITY
    Inventors: Timothy E. Kennedy, Jean-Pierre Clement, Laila Al-Alwan
  • Publication number: 20230016634
    Abstract: The present disclosure concerns a cell or tissue culture system comprising a solid support for the culture of adherent cells or adherent tissues and a plurality of cationic dendrimers associated to the surface of the solid support. Each cationic dendrimer includes one or more functional amine group. The cationic dendrimer is protonated at physiological pH. The cell or tissue culture system can be used for the culture of adherent cells or tissues and be used for the differentiation of stem cells.
    Type: Application
    Filed: April 19, 2022
    Publication date: January 19, 2023
    Inventors: Timothy E. KENNEDY, Jean-Pierre CLEMENT, Laila AL-ALWAN
  • Publication number: 20120178690
    Abstract: Netrin proteins and their receptors regulate cell and axon migration, and are implicated in tissue morphogenesis, tumorigenesis and angiogenesis. Deregulation of mechanisms that control cell motility plays a key role in tumor progression by promoting tumor cell dissemination. Unwanted neovascularization also contributes to tumor progression and metastasis and to ocular diseases which are a leading cause of blindness. Here, we describe novel netrin-derived polypeptides and fragments or derivatives thereof that selectively inhibit cell growth, migration or branching. Methods and compositions for the treatment and prevention of conditions involving cell migration or neovascularization, such as cancer and ocular disease, are also provided.
    Type: Application
    Filed: June 9, 2010
    Publication date: July 12, 2012
    Applicant: The Royal Institution for the Advancement of Learning/McGill University
    Inventor: Timothy E. Kennedy